Canadian response to legalisation has shown that cannabis is a huge growth industry with investment potential
Investors concerned about the
volatility of Bitcoin should instead plough their funds into medical cannabis,
a leading wealth adviser has urged.
Carol Pepper, CEO and founder of New
York-based Pepper International, branded cannabis stocks as “the next huge
growth area” laden with “staggering opportunities” in the world of medicine.
Speaking to CNBC’s Squawk Box, she
explained how Canada’s legalisation of medicinal cannabis in July 2018 had
“blown through all expectations” as an investor opportunity.
“If you want to be in something that’s
very growthy and actually legitimate as it is legalised and controlled
properly, I think this is the place to go,” she said.
Both Nasdaq and the New York Stock
Exchange listed two prominent Canada-based cannabis firms soon after the
regulations changed – Canopy Growth and Cronos Group.
The stock value of Canopy Growth has
currently risen by more than 65 per cent, while Cronos is exceeding 115 per
“The medical applications for cannabis
are staggering,” added Mrs Pepper.
“The research is being done and I
really think this is next huge growth area.
“I think it is a phenomenal plant that
is going to do a lot of good for the planet and I’m glad it is finally being
She went on to highlight work being
done on CBD’s potential in the treatment of conditions such as arthritis and
epilepsy. When asked if cannabis-derived products were likely to mirror the
volatility of cryptocurrency markets, she replied with a firm rejection
pointing to it being a ‘physical product with defined benefits’.